Sign in
4

Changes in Ownership

Aptevo Therapeutics Inc. Filed Acc 0000950170-25-105922

Options or other derivatives

  • President and CEO acquired 30,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
White Marvin L President and CEO 2025-08-06 Grant or award · Restricted Stock Unit +30,000 30,000 D
Loading xslF345X05/ownership.xml…